Clinical trial
Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes…
NCT00371124 · Singapore National Eye Centre, Other · Unknown status
Key facts
| NCT number | NCT00371124 |
|---|---|
| Title | Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In Children |
| Official title | A Randomised, Double-Masked Study to Compare The Safety and Efficacy of Bilateral 0.5%, 0.1% & 0.01% Atropine Treatment In Controlling Progression of Myopia In Children |
| Lead sponsor | Singapore National Eye Centre, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Myopia |
| Intervention type | Drug |
| Interventions | Atropine Eye drops |
| Enrollment | 400 |
| Start date | Mar 1, 2006 |
| First posted | Sep 1, 2006 |
| Last update posted | Aug 31, 2010 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: